Search
Patexia Research
Case number 1:20-cv-00293

ViiV Healthcare Company et al v. Lupin Limited et al > Documents

Date Field Doc. No.Description (Pages)
Mar 30, 2022 39 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986 and 10,426,780. (nmg)
Mar 30, 2022 38 Consent Judgment (3)
Docket Text: CONSENT JUDGMENT. Signed by Judge Mitchell S. Goldberg on 3/30/2022. (nmg)
Mar 25, 2022 37 Redacted Document (2)
Docket Text: REDACTED VERSION of [35] Letter by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra)
Mar 24, 2022 36 Proposed Consent Judgment (3)
Docket Text: PROPOSED CONSENT JUDGMENT and Dismissal by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra)
Feb 11, 2022 34 Stipulation and Order (5)
Docket Text: STIPULATION AND ORDER amending dates of the Scheduling Order entered on December 14, 2021. No other dates set forth in the Scheduling Order shall be amended absent an order of this Court. Signed by Judge Mitchell S. Goldberg on 2/11/2022. Associated Cases: 1:20-cv-00977-MSG, 1:19-cv-02085-MSG, 1:20-cv-00293-MSG(nmg)
Feb 9, 2022 33 Stipulation to EXTEND Time (5)
Docket Text: STIPULATION TO EXTEND TIME Various Deadlines to Various Dates Listed - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Phillips, John)
Jan 31, 2022 32 Stipulation and Order (3)
Docket Text: STIPULATION AND ORDER re [31] STIPULATION TO EXTEND TIME Rule 26 Disclosures & Paragraph 3 Disclosures to February 11, 2022 and February 18, 2022. No other dates set forth in the Scheduling Order shall be amended absent an order of this Court. Signed by Judge Mitchell S. Goldberg on 1/31/2022. (nmg)
Jan 27, 2022 31 Stipulation to EXTEND Time (3)
Docket Text: STIPULATION TO EXTEND TIME Rule 26 Disclosures & Paragraph 3 Disclosures to February 11, 2022 and February 18, 2022 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Bilson, David)
Dec 14, 2021 30 Stipulation and Order (11)
Docket Text: STIPULATED SCHEDULING ORDER: ( Joinder of Parties due by 1/27/2023., Fact Discovery completed by 2/24/2023., Opening Expert Reports due by 8/11/2023., Rebuttal Expert Reports due by 9/8/2023., Expert Discovery due by 11/10/2023., A claim construction hearing is set for 2/8/2023 at 10:00 AM in Philadelphia before Judge Mitchell S. Goldberg. See Order for further details). Signed by Judge Mitchell S. Goldberg on 12/14/2021. Associated Cases: 1:19-cv-02085-MSG, 1:20-cv-00293-MSG, 1:20-cv-00977-MSG(smg)
Dec 1, 2021 29 Stipulated Scheduling Order (11)
Dec 1, 2021 29 Main Document (1)
Docket Text: Letter to The Honorable Mitchell S. Goldberg from Daniel M. Silver, Esq. regarding Stipulated Case Scheduling Order - re (21 in 1:20-cv-00977-MSG, 21 in 1:20-cv-00977-MSG, 22 in 1:19-cv-02085-MSG, 22 in 1:19-cv-02085-MSG, 26 in 1:20-cv-00293-MSG, 26 in 1:20-cv-00293-MSG) Order,,, Set Deadlines,,. (Attachments: # (1) Stipulated Scheduling Order)(Silver, Daniel)
Nov 30, 2021 28 Stipulation and Order (3)
Docket Text: STIPULATION AND ORDER, the deadline for the parties to submit a proposed case schedule is extended through and including Wednesday, December 1, 2021 (from Thursday, November 25, 2021). Signed by Judge Mitchell S. Goldberg on 11/30/2021. Associated Cases: 1:20-cv-00977-MSG, 1:19-cv-02085-MSG, 1:20-cv-00293-MSG(nmg)
Nov 24, 2021 27 Stipulation to EXTEND Time (3)
Docket Text: STIPULATION TO EXTEND TIME the Parties to Submit a Proposed Case Schedule to December 1, 2021 - filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Silver, Daniel)
Oct 26, 2021 26 Order (2)
Docket Text: ORDER, Counsel for all parties shall meet and confer in an effort to agree on a schedule for the three above-captioned cases. By November 25, 2021, the parties shall submit a joint letter proposing a schedule for the three above-captioned cases. The proposed schedule shall include deadlines for any remaining fact discovery, expert discovery, dispositive motions, and Daubert motions, and shall provide dates when all counsel and witnesses are available to be attached for trial. Signed by Judge Mitchell S. Goldberg on 10/26/2021. Associated Cases: 1:20-cv-00293-MSG, 1:19-cv-02085-MSG, 1:20-cv-00977-MSG (nmg)
Oct 26, 2021 N/A Telephone Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Telephone Conference held on 10/26/2021. Associated Cases: 1:20-cv-00293-MSG, 1:19-cv-02085-MSG, 1:20-cv-00977-MSG(nmg)
Oct 15, 2021 25 Order Setting Teleconference (2)
Docket Text: ORDER, a TELEPHONE CONFERENCE is scheduled for Tuesday, October 26, 2021 at 9:30 a.m. The conference will be conducted via telephone. Counsel are directed to dial in as follows:(1) Call: 888-684-8852; (2) Enter access code: 2187450#; (3) Press # to enter as a participant. Signed by Judge Mitchell S. Goldberg on 10/15/2021. Associated Cases: 1:20-cv-00293-MSG, 1:19-cv-02085-MSG, 1:20-cv-00977-MSG(smg)
Oct 8, 2021 24 Letter (1)
Docket Text: Joint Letter to The Honorable Mitchell S. Golberg from Daniel M. Silver, Esq. regarding Status Update. (Silver, Daniel)
Oct 6, 2021 23 Letter (1)
Docket Text: Letter to The Honorable Mitchell S. Goldberg from Daniel M. Silver, Esq. regarding Joint Request to Provide Status Update on October 8, 2021. (Silver, Daniel)
Sep 15, 2021 22 Redacted Document (2)
Docket Text: REDACTED VERSION of [20] Letter by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Silver, Daniel)
Sep 8, 2021 21 Notice Requesting Removal of Co-Counsel (1)
Docket Text: NOTICE requesting Clerk to remove Amy D. Brody as co-counsel. Reason for request: No long with firm.. (Bilson, David)
Aug 25, 2021 19 Order (2)
Docket Text: ORDER, within 14 days from the date of this Order, the parties shall file a joint letter regarding the status of each matter, including whether any fact and/or expert discovery is still needed. (See Order for further details) Signed by Judge Mitchell S. Goldberg on 08/25/2021. Associated Cases: 1:20-cv-00293-MSG, 1:19-cv-02085-MSG, 1:20-cv-00977-MSG(smg)
Jan 19, 2021 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: DI 19 Removed due to filing in incorrect civil action. (apk)
Sep 16, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Carolyn Wall for Shionogi & Co., Ltd., for ViiV Healthcare Company, for ViiV Healthcare UK (No. 3) Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-02085-MSG, 1:20-cv-00977-MSG (myr)
Sep 16, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Caitlin Hogan for Shionogi & Co., Ltd., for ViiV Healthcare Company, for ViiV Healthcare UK (No. 3) Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-02085-MSG, 1:20-cv-00977-MSG (myr)
Sep 16, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Lisa B. Pensabene for Shionogi & Co., Ltd.,for ViiV Healthcare Company, for ViiV Healthcare UK (No. 3) Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-02085-MSG, 1:20-cv-00977-MSG (myr)
Sep 16, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Daniel O'Boyle for Shionogi & Co., Ltd., for ViiV Healthcare Company, for ViiV Healthcare UK (No. 3) Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-02085-MSG, 1:20-cv-00977-MSG (myr)
Sep 14, 2020 18 Order on Motion to Appear Pro Hac Vice (2)
Docket Text: ORDER granting (15) MOTION for Pro Hac Vice Appearance of Attorney Lisa B. Pensabene, Daniel OBoyle, Carolyn Wall, and Caitlin Hogan in case 1:19-cv-02085-MSG; granting (17) MOTION for Pro Hac Vice Appearance of Attorney Lisa B. Pensabene, Daniel OBoyle, Carolyn Wall, and Caitlin Hogan in case 1:20-cv-00293-MSG; granting (10) MOTION for Pro Hac Vice Appearance of Attorney Lisa B. Pensabene, Daniel OBoyle, Carolyn Wall, and Caitlin Hogan in case 1:20-cv-00977-MSG. Signed by Judge Mitchell S. Goldberg on 9/14/2020. Associated Cases: 1:19-cv-02085-MSG, 1:20-cv-00293-MSG, 1:20-cv-00977-MSG(nmg)
Sep 9, 2020 17 Main Document (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Lisa B. Pensabene, Daniel OBoyle, Carolyn Wall, and Caitlin Hogan - filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Attachments: # (1) Certifications for Lisa B. Pensabene, Daniel OBoyle, Carolyn Wall, and Caitlin Hogan)(Silver, Daniel)
Sep 9, 2020 17 Certifications for Lisa B. Pensabene, Daniel OBoyle, Carolyn Wall, and Caitlin (4)
Apr 28, 2020 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: Removed Disclosure Statement per request of filer. (rwc)
Apr 14, 2020 16 Disclosure Statement (2)
Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited for Lupin Pharmaceuticals, Inc. filed by Lupin Pharmaceuticals, Inc.. (Bilson, David)
Apr 13, 2020 15 Answer to Counterclaim (14)
Docket Text: ANSWER to [9] Answer to Complaint, Counterclaim by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited.(Silver, Daniel)
Mar 25, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Xiaomei Cai for Lupin Limited,for Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Mar 25, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Amy D. Brody for Lupin Limited,for Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Mar 25, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney William A. Rakoczy for Lupin Limited,for Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Mar 25, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Matthew V. Anderson for Lupin Limited, for Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Mar 24, 2020 14 Redacted Document (30)
Docket Text: REDACTED VERSION of [9] Answer to Complaint, Counterclaim by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Bilson, David)
Mar 24, 2020 13 Order on Motion to Appear Pro Hac Vice (2)
Docket Text: ORDER granting [12] Motion to Appear Pro Hac Vice for William A. Rakoczy, Paul J. Molino, Amy D. Brody, Matthew V. Anderson and Xiaomei Cai to represent Defendants Lupin Limited and Lupin Pharmaceuticals, Inc. Signed by Judge Mitchell S. Goldberg on 3/24/2020. (lak)
Mar 20, 2020 12 Certification of Xiaomei Cai (1)
Mar 20, 2020 12 Certification of Matthew V. Anderson (1)
Mar 20, 2020 12 Certification of Amy D. Brody (1)
Mar 20, 2020 12 Certification of Paul J. Molino (1)
Mar 20, 2020 12 Certification of William A. Rakoczy (1)
Mar 20, 2020 12 Main Document (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Paul J. Molino, Amy D. Brody, Matthew V. Anderson and Xiaomei Cai - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # (1) Certification of William A. Rakoczy, # (2) Certification of Paul J. Molino, # (3) Certification of Amy D. Brody, # (4) Certification of Matthew V. Anderson, # (5) Certification of Xiaomei Cai)(Bilson, David)
Mar 20, 2020 11 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited for Lupin Pharmaceuticals, Inc. filed by Lupin Pharmaceuticals, Inc.. (Phillips, John)
Mar 20, 2020 10 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Lupin Limited. (Phillips, John)
Mar 4, 2020 8 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd.. Lupin Pharmaceuticals, Inc. served on 2/28/2020, answer due 3/20/2020. (Silver, Daniel)
Mar 4, 2020 7 Exhibit A-B (6)
Mar 4, 2020 7 Main Document (2)
Docket Text: DECLARATION of Mailing regarding service on Lupin Limited made on February 28, 2020 by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Attachments: # (1) Exhibit A-B)(Silver, Daniel)
Mar 4, 2020 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Mitchell S. Goldberg of the U.S. District Court for the Eastern District of Pennsylvania (due to related cases). Please include the initials of the Judge (MSG) after the case number on all documents filed. (rjb)
Feb 28, 2020 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Lupin Limited on 2/28/2020; Lupin Pharmaceuticals, Inc. on 2/28/2020. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (myr)
Feb 28, 2020 6 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Shionogi & Co., Ltd. (myr)
Feb 28, 2020 5 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent GlaxoSmithKline plc, Other Affiliate Pfizer Inc., Other Affiliate Shionogi Limited for ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited filed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (myr) (Main Document 5 replaced on 2/28/2020) (nmg).
Feb 28, 2020 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986 ;10,426,780. (myr)
Feb 28, 2020 3 ANDA Form (2)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: January 16, 2020. Date of Expiration of Patent: December 8, 2029, January 24, 2031.Thirty Month Stay Deadline: 7/16/2022. (myr)
Feb 28, 2020 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr)
Feb 28, 2020 1 Civil Cover Sheet (2)
Feb 28, 2020 1 Exhibit A-B (46)
Feb 28, 2020 1 Main Document (12)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-2865964.) - filed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd.. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(myr)
Feb 28, 2020 1 Complaint* (1)
Menu